| 0.45 Data as of May 24 |  -0.02 / -4.26%Today’s Change | 0.22 Today|||52-Week Range 3.99 | -26.84% Year-to-Date |
| Previous close | 0.47 |
| Today’s open | 0.42 |
| Day’s range | 0.42 - 0.45 |
| Volume | 43,864 |
| Average volume (3 months) | 78,694 |
| Market cap | -- |
| Dividend yield | -- |
| Earnings growth (last year) | +10.23% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +74.93% |
| P/E ratio | NM |
| Price/Sales | 21.07 |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | June 13, 2013 |
| EPS forecast (this quarter) | $0.08 |
| Annual revenue (last year) | $812.0K |
| Annual profit (last year) | -$8.9M |
| Net profit margin | -1,094.83% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael L. Krall |
Chief Financial & Accounting Officer Peter C. Wulff, MBA |
Corporate headquarters El Cajon, California |
.
